Document is current
Any future updates will be listed below
-
Authors
Rojo Domingo, Mariluz
Conlin, Christopher C.
Karunamuni, Roshan
Ollison, Courtney
Baxter, Madison T.
Kallis, Karoline
Do, Deondre D.
Song, Yuze
Kuperman, Joshua
Shabaik, Ahmed S.
Hahn, Michael E.
Murphy, Paul M.
Rakow-Penner, Rebecca
Dale, Anders M.
Seibert, Tyler M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH/NIBIB K08EB026503, NIH UL1TR000100)
American Society for Radiation Oncology
Prostate Cancer Foundation (PCF20YOUN01)
U.S. Department of Defense (DOD/CDMRP PC220278)
- License Information
-
More Information
Article History
Received: 5 June 2024
Accepted: 9 December 2024
First Online: 28 December 2024
Declarations
:
: M.E.H. reports honoraria from Multimodal Imaging Services Corporation and research funding from GE Healthcare. R.R.P. has an equity interest in CorTechs Labs and Curemetrix, serves on the scientific advisory board of Imagine Scientific, and has received consulting fees from Bayer and research funding from GE Healthcare. A.M.D. is a founder of and holds equity in CorTechs Labs, Inc, and serves on its scientific advisory board; he also is a member of the scientific advisory board of Human Longevity, Inc, and receives funding through research agreements with GE Healthcare. T.M.S. reports honoraria from CorTechs Labs, Varian Medical Systems, WebMD, GE Healthcare, and Janssen; has an equity interest in CorTechs Labs, Inc, and serves on its scientific advisory board; and has received in-kind research support from GE Healthcare via a research agreement with the University of California, San Diego. These companies might potentially benefit from the research results. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. All the remaining authors declare no conflict of interest.
